Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 2/20 | 0.67 |
| ▸ | HTT | P42858 | 2/20 | 0.67 |
| ▸ | MEN1 | O00255 | 1/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.67 |
| ▸ | MAPT | P10636 | 1/20 | 0.67 |
| ▸ | CES2 | O00748 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | CES1 | P23141 | 1/20 | 0.48 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.44 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.44 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL722492 | 1.00 | THRB (0.67) | THRBHTTMEN1KMT2AMAPT | |
| Ammonia Solution, Strong SCHEMBL2587274 | 1.00 | THRB (0.67) | THRBHTTMEN1KMT2AMAPT | |
| Ammonia Solution, Strong SCHEMBL715799 | 1.00 | THRB (0.67) | THRBHTTMEN1KMT2AMAPT | |
| Ammonia Solution, Strong SCHEMBL4438557 | 1.00 | THRB (0.67) | THRBHTTMEN1KMT2AMAPT | |
| Ammonia Solution, Strong SCHEMBL2587267 | 1.00 | THRB (0.67) | THRBHTTMEN1KMT2AMAPT | |
| Ammonia Solution, Strong SCHEMBL715250 | 1.00 | THRB (0.67) | THRBHTTMEN1KMT2AMAPT | |
| Ammonia Solution, Strong SCHEMBL2583073 | 1.00 | THRB (0.67) | THRBHTTMEN1KMT2AMAPT | |
| Ammonia Solution, Strong SCHEMBL6009607 | 1.00 | THRB (0.67) | THRBHTTMEN1KMT2AMAPT | |
| Ammonia Solution, Strong SCHEMBL715486 | 1.00 | THRB (0.67) | THRBHTTMEN1KMT2AMAPT | |
| Ammonia Solution, Strong SCHEMBL27640240 | 1.00 | THRB (0.67) | THRBHTTMEN1KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 222 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2032523-B1 | PROCESS FOR PREPARATION OF ALKOXYLATED ALKYLAMINES / ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | AKZO NOBEL NV (NL) | 2012-06-20 | — | — | EP | claimed |
| US-8049039-B2 | Process for preparation of alkoxylated alkylamines/alkyl ether amines with peaked distribution | AKZO NOBEL N.V. (NL) | 2011-11-01 | — | — | US | claimed |
| US-20090209788-A1 | PROCESS FOR PREPARATION OF ALKOXYLATED ALKYLAMINES/ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | AKZO NOBEL N.V. (NL) | 2009-08-20 | — | — | US | claimed |
| EP-2032523-A1 | PROCESS FOR PREPARATION OF ALKOXYLATED ALKYLAMINES / ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | Akzo Nobel N.V. (NL) | 2009-03-11 | — | — | EP | claimed |
| WO-2007147866-A1 | PROCESS FOR PREPARATION OF ALKOXYLATED ALKYLAMINES / ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | AKZO NOBEL N.V. (NL) | 2007-12-27 | — | — | WO | claimed |
| WO-2026087745-A1 | AN ANTIOXIDANT COMPOSITION COMPRISING A CINNAMIC ACID DERIVATIVE | BRAIN Biotech AG (DE) | 2026-04-30 | — | — | WO | disclosed |
| EP-4732825-A1 | AN ANTIOXIDANT COMPOSITION COMPRISING A CINNAMIC ACID DERIVATIVE | BRAIN Biotech AG (DE) | 2026-04-29 | — | — | EP | disclosed |
| US-20260096978-A1 | A METHOD FOR PREVENTING, MITIGATING AND/OR TREATING PTGS2-INDUCED SKIN DISORDERS AND RELATED DYSFUNCTIONS | SYMRISE AG (DE) | 2026-04-09 | — | — | US | disclosed |
| EP-4186969-B1 | SUPER-CONCENTRATED DILUTABLE POWDER FOR DISHWASHING APPLICATION | HENKEL AG & CO KGAA (DE) | 2026-04-01 | — | — | EP | disclosed |
| EP-4025675-B1 | A PERFUME OIL MIXTURE | SYMRISE AG (DE) | 2026-03-18 | — | — | EP | disclosed |
| US-20260047994-A1 | AN ACTIVE COMPOSITION COMPRISING RETINOL | SYMRISE AG (DE) | 2026-02-19 | — | — | US | disclosed |
| US-20260041094-A1 | Compositions Comprising an Antimicrobial Boosting Agent | SYMRISE AG (DE) | 2026-02-12 | — | — | US | disclosed |
| EP-2032523-A1 | PROCESS FOR PREPARATION OF ALKOXYLATED ALKYLAMINES / ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | Akzo Nobel N.V. (NL) | 2009-03-11 | — | — | EP | disclosed |
| WO-2007109791-A9 | ALKOXYLATED ALKYLAMINES OR ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | AKZO NOBEL NV (NL) | 2009-01-15 | — | — | WO | disclosed |
| EP-2003965-A2 | ALKOXYLATED ALKYLAMINES OR ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | Akzo Nobel N.V. (NL) | 2008-12-24 | — | — | EP | disclosed |
| US-20080261814-A1 | Alkoxylated Alkylamines/Alkyl Ether Amines With Peaked Distribution | MONSANTO TECHNOLOGY LLC (US) | 2008-10-23 | — | — | US | disclosed |
| WO-2007147866-A1 | PROCESS FOR PREPARATION OF ALKOXYLATED ALKYLAMINES / ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | AKZO NOBEL N.V. (NL) | 2007-12-27 | — | — | WO | disclosed |
| WO-2007109791-A2 | ALKOXYLATED ALKYLAMINES OR ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | AKZO NOBEL N.V. (NL) | 2007-09-27 | — | — | WO | disclosed |
| EP-1793667-A1 | ALKOXYLATED ALKYLAMINES / ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | Akzo Nobel N.V. (NL) | 2007-06-13 | — | — | EP | disclosed |
| WO-2006034459-A1 | ALKOXYLATED ALKYLAMINES / ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | AKZO NOBEL N.V. (NL) | 2006-03-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090209788-A1 | PROCESS FOR PREPARATION OF ALKOXYLATED ALKYLAMINES/ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | ALKBH3, ALKBH2, ALKBH5 | THRB 4617/4885HTT 1612/4885MEN1 1829/4885 |
| US-20260041094-A1 | Compositions Comprising an Antimicrobial Boosting Agent | TLR7, MYC, ERG28 | THRB 1828/4885HTT 1226/4885MEN1 1776/4885 |
| US-20080261814-A1 | Alkoxylated Alkylamines/Alkyl Ether Amines With Peaked Distribution | ALKBH3, ALKBH2, ALKBH1 | THRB 4460/4885HTT 1421/4885MEN1 2669/4885 |
| US-20260047994-A1 | AN ACTIVE COMPOSITION COMPRISING RETINOL | RBP4, LRAT, RARB | THRB 82/4885HTT 3387/4885MEN1 3391/4885 |
| US-20260096978-A1 | A METHOD FOR PREVENTING, MITIGATING AND/OR TREATING PTGS2-INDUCED SKIN DISORDERS AND RELATED DYSFUNCTIONS | PTGS2, PTGES2, PTGS1 | THRB 2049/4885HTT 1649/4885MEN1 2489/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.